Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 10.88K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --10.88K | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -59.23%335.03K | -53.95%415.98K | -10.91%703.51K | -24.73%3.91M | 34.42%1.4M | -7.25%821.82K | -42.76%903.36K | -53.79%789.67K | -13.09%5.2M | -46.95%1.04M |
| Selling and administrative expenses | -54.30%200.07K | -46.47%271.37K | -23.37%445.74K | 1.17%2.64M | 119.75%1.11M | -28.00%437.78K | -27.03%506.94K | -28.38%581.69K | 44.82%2.61M | -21.70%504.37K |
| -General and administrative expense | -54.30%200.07K | -46.47%271.37K | -23.37%445.74K | 1.17%2.64M | 119.75%1.11M | -28.00%437.78K | -27.03%506.94K | -28.38%581.69K | 44.82%2.61M | -21.70%504.37K |
| Research and development costs | -64.86%134.96K | -63.52%144.61K | 23.94%257.78K | -50.77%1.28M | -46.15%287.66K | 38.13%384.04K | -55.12%396.42K | -76.80%207.98K | -37.53%2.59M | -59.30%534.17K |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Operating profit | 59.23%-335.03K | 53.95%-415.98K | 12.29%-692.64K | 24.73%-3.91M | -34.42%-1.4M | 7.25%-821.82K | 42.76%-903.36K | 53.79%-789.67K | 13.09%-5.2M | 46.95%-1.04M |
| Net non-operating interest income (expenses) | 102.82%1.19K | 105.01%2.2K | 6.32%-33.33K | -751.84%-164.07K | -115.30%-42.36K | 85.69%-42.36K | -43.78K | -35.57K | -1,852.59%-19.26K | 16,302.37%276.87K |
| Non-operating interest income | --1.19K | --2.2K | --6.46K | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Non-operating interest expense | ---- | ---- | 11.84%39.78K | 751.84%164.07K | 115.30%42.36K | -85.69%42.36K | --43.78K | --35.57K | --19.26K | ---276.87K |
| Other net income (expenses) | -34.87K | 2.37K | 17.54K | -15.18K | ||||||
| Special income (charges) | --0 | --0 | ---34.87K | --2.37K | --17.54K | --0 | ---15.18K | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | --34.87K | ---22.83K | ---38.01K | ---- | --15.18K | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---20.47K | ---- | ---- | ---- | ---- | --0 | ---- |
| Income before tax | 61.37%-333.84K | 57.00%-413.78K | 7.80%-760.83K | 21.91%-4.07M | -86.54%-1.42M | 26.02%-864.18K | 39.02%-962.31K | 51.71%-825.24K | 12.75%-5.22M | 61.06%-761.66K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 61.37%-333.84K | 57.00%-413.78K | 7.80%-760.83K | 21.91%-4.07M | -86.54%-1.42M | 26.02%-864.18K | 39.02%-962.31K | 51.71%-825.24K | 12.75%-5.22M | 61.06%-761.66K |
| Net income continuous operations | 61.37%-333.84K | 57.00%-413.78K | 7.80%-760.83K | 21.91%-4.07M | -86.54%-1.42M | 26.02%-864.18K | 39.02%-962.31K | 51.71%-825.24K | 12.75%-5.22M | 61.06%-761.66K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 61.37%-333.84K | 57.00%-413.78K | 7.80%-760.83K | 21.91%-4.07M | -86.54%-1.42M | 26.02%-864.18K | 39.02%-962.31K | 51.71%-825.24K | 12.75%-5.22M | 61.06%-761.66K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 61.37%-333.84K | 57.00%-413.78K | 7.80%-760.83K | 21.91%-4.07M | -86.54%-1.42M | 26.02%-864.18K | 39.02%-962.31K | 51.71%-825.24K | 12.75%-5.22M | 61.06%-761.66K |
| Diluted earnings per share | 0 | 0.00%-0.01 | 0.00%-0.01 | 14.29%-0.06 | -100.00%-0.02 | 50.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 30.00%-0.07 | 66.67%-0.01 |
| Basic earnings per share | 0 | 0.00%-0.01 | 0.00%-0.01 | 14.29%-0.06 | -100.00%-0.02 | 50.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 30.00%-0.07 | 66.67%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.